Stem cell therapy of the affected limb ischemic diseases are not always clearly leads to recovery. Quite often in the treatment there are severe inflammation and death of a large number of previously healthy cells.
Millions of people suffer from coronary diseases. In this case, in the human body interferes with the normal blood flow to different parts of the body, which leads to chronic wounds in the limbs, acute heart attacks and internal organ.
Developed methods of treatment of such diseases by stem cells, which are aimed at restoring optimal blood flow. Application of these methods renews the blood supply to areas of its violation due to the growth of new blood vessels that often accompany the development of inflammatory processes and the withering away of the huge number of cells in the tissues. This process it resembles the power generation with cooling switched off.
Scientists noticed that during intrauterine development the fetus is produced by a special enzyme indolin 2.3 dioxygenase (IIDO), which allows to avoid rejection of the growing organism, the immune system of the mother by inhibiting inflammatory processes.
Identified an enzyme researchers have tried to enter during therapy with stem cells.The results of the experiment confirmed the validity of this approach.
Currently, we are conducting a thorough study of the interaction of the enzyme and stem cells in the treatment of chronic ulcers, wounds that accompany coronary disease.